13 results
·
22ms
·
Sources: EU EUDAMED, US FDA
Cryon-X Cold Compression
FDA 510(k)
FDA Class 2
·Physical Medicine
APEX Knee System
FDA UDI
Omni Life Science, Inc.·00841690197096·Revision Knee Spiral Reamer- Hudson Short Flute...
PINN CUP IMPACTOR TIP 32MM
FDA Adverse Event
Malfunction
·DEPUY ORTHOPAEDICS INC US·Product code HWA·January 30, 2026
Ophthalmic Knife
FDA UDI
KATENA PRODUCTS, INC.·00841668101261·SWISS MODEL BLADE BREAKER
ARTICUL/EZE
FDA UDI
DEPUY ORTHOPAEDICS, INC.·10603295129172·ARTICUL/EZE TRIAL HEAD 36mm -2
Truliant
FDA UDI
Exactech, Inc.·10885862556332·TRIAL, TIBIAL INSERT, CR, NEUTRAL, SIZE 5
ONE TOUCH ULTRA
FDA Adverse Event
Malfunction
·LIFESCAN, INC.·Product code CFR·October 8, 2003
AUTOLoader, and NOVA view with models: ALDR1000, AND NV2000
FDA 510(k)
FDA Class 2
·Immunology
Cool-tip RF Ablation System E Series
FDA 510(k)
FDA Class 2
·General, Plastic Surgery
SPROTTE
FDA Adverse Event
Other
·PAJUNK GMBH MEDIZINTECHNOLOGIE·Product code BSP·August 23, 2011
SYNCHROMED II
FDA Adverse Event
Injury
·MEDTRONIC PUERTO RICO OPERATIONS CO.·Product code LKK·December 5, 2008
ULTRACISION HARMONIC ACE
FDA Adverse Event
Malfunction
·ETHICON ENDO-SURGERY, LLC.·Product code LFL·July 29, 2013
Stryker T2 Arthrodesis Nailing System. Manufacturer: Stryker Trauma GmbH, Professor-Kuntscher-Str. 1-5, 24232 Schonkirchen Germany. Distributed in the USA by Stryker Orthopaedics, 325 Corporate Drive, Mahwah, NJ 07430. The T2 Arthrodesis Nail is intended for the treatment of Knee Arthrodesis. The design of the T2 Arthrodesis Nail features a unique curvature which incorporates both femur ante curvature and knee valgus bend. Indications: Aseptic failed total knee arthro-plasty with or without bone loss; Failed external fixation, non unions and malunions; Periarticular fractures where repair is not possible; Pathologic fractures and tumor resections; Pseudoarthrosis and correct osteotomy; Ipsilateral femur fractures; and Open and closed femoral fractures.
FDA Enforcement
Class II
·Terminated·Stryker Howmedica Osteonics Corp.·July 25, 2012